In the largest comparison of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors to date, a study of nearly 2.3 million patients starting the drugs as monotherapy ...
A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...
In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...
September 13, 2012 – Angiotensin-receptor blocker (ARB) therapy may cut the risk of Alzheimer's disease (AD) by reducing amyloid deposition in the brain, a new study hints. The study, based on ...
Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A controversial study suggesting COVID-19 may be more severe in some ...
Do ACE inhibitors or angiotensin II receptor blockers (ARBs) offer renal protection to patients with diabetes or renal disease?— Negeen Farmand, PA-C, Los Angeles When should a clinician stop an ACE ...
PHILADELPHIA – Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) may represent effective migraine prophylactic treatments, according to the results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results